A Study of Aticaprant as Adjunctive Therapy in Adult Participants With Major Depressive Disorder (MDD) With Moderate-to-severe Anhedonia and Inadequate Response to Current Antidepressant Therapy
Clinical trial NCT05455684 · COMPLETED
Trial details
- NCT number
- NCT05455684
- Sponsor
- Janssen Research & Development, LLC
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-06-22
- Primary completion
- 2024-09-18
- Enrollment
- 513
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.